200 related articles for article (PubMed ID: 8381558)
1. Hormonal chemoprevention of cancer in women.
Henderson BE; Ross RK; Pike MC
Science; 1993 Jan; 259(5095):633-8. PubMed ID: 8381558
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cancers of the breast, endometrium and ovary.
Pike MC; Pearce CL; Wu AH
Oncogene; 2004 Aug; 23(38):6379-91. PubMed ID: 15322512
[TBL] [Abstract][Full Text] [Related]
3. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
4. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
5. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
7. Update on cancer control in women.
Boyle P; Maisonneuve P; Autier P
Int J Gynaecol Obstet; 2000 Aug; 70(2):263-303. PubMed ID: 10960611
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
[TBL] [Abstract][Full Text] [Related]
9. Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Steele VE; Lubet RA; Sigman CC
J Cell Biochem Suppl; 1995; 23():1-9. PubMed ID: 8747372
[TBL] [Abstract][Full Text] [Related]
10. Hormonal contraception and chemoprevention of female cancers.
Pike MC; Spicer DV
Endocr Relat Cancer; 2000 Jun; 7(2):73-83. PubMed ID: 10903525
[TBL] [Abstract][Full Text] [Related]
11. Ovarian and endometrial function during hormonal contraception.
ESHRE Capri Workshop Group
Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
[TBL] [Abstract][Full Text] [Related]
12. Noncontraceptive health benefits of oral steroidal contraceptives.
Mishell DR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
[TBL] [Abstract][Full Text] [Related]
13. Medicinal drugs with hormonal activity as chemopreventive agents.
Cuzick J
IARC Sci Publ; 1996; (139):99-114. PubMed ID: 8923022
[TBL] [Abstract][Full Text] [Related]
14. In pursuit of the prevention of breast cancer.
Yardley DA
Am J Med Sci; 2000 Oct; 320(4):263-72. PubMed ID: 11061352
[No Abstract] [Full Text] [Related]
15. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen's role in chemoprevention of breast cancer: an update.
Nayfield SG
J Cell Biochem Suppl; 1995; 22():42-50. PubMed ID: 8538209
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk and PCOS.
Dumesic DA; Lobo RA
Steroids; 2013 Aug; 78(8):782-5. PubMed ID: 23624028
[TBL] [Abstract][Full Text] [Related]
18. Progestogens in estrogen-replacement therapy.
Gambrell RD
Clin Obstet Gynecol; 1995 Dec; 38(4):890-901. PubMed ID: 8616984
[No Abstract] [Full Text] [Related]
19. The use of hormonal contraception and its protective role against endometrial and ovarian cancer.
Grimbizis GF; Tarlatzis BC
Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):29-38. PubMed ID: 19879809
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials referral resource. Breast cancer and prostate cancer.
Brawley OW; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
